NOVOS AMA  with CEO Chris Mirabile - EARD 2022 @LifespanIO
NOVOS AMA  with CEO Chris Mirabile - EARD 2022  @LifespanIO
Uploaded October 2022 | Updated November 2026, 5 days ago
Stephanie Dainow, Executive Director of Lifespan.io, conducts an Ask Me Anything session with Chris Mirabile, founder & CEO of NOVOS, at the annual Ending Age-Related Diseases (EARD) Conference 2022.

NOVOS is the only solution designed to address the 10 scientifically proven root causes of aging. Their world-renowned team of longevity scientists and doctors have developed innovative supplements to slow aging and unlock vitality.

Visit their website here:
novoslabs.com

FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
lifespan.io
facebook.com/lifespanio
instagram.com/lifespan.io

HELP SUPPORT US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Lifespan.io, a 501(c)(3) nonprofit organization.
► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero
► Subscribe: youtube.com/user/LifespanIO
► Learn more, and help us: lifespan.io

#EARD2022 #Lifespan #StephanieDainow #ChrisMirabile #NOVOS #NOVOSCore #NOVOSBoost #NMN #nicotinamidemononucleotide
NOVOS AMA  with CEO Chris Mirabile - EARD 2022Rejuvenation Roundup Podcast - July 2022Longevity+DeSci Summit NYC 2023 RecapRejuvenation Roundup July 2021Building a Pipeline of Therapeutics that Target Diseases of AgingRejuvenating the Heart with Extracellular Vesicles from Stem CellsSavva Kerdemelidis at EARD 2022: Using Financial Innovation to Incentivize Longevity MedicineEpigenetics Clocks to Identify Novel Ani-Aging Interventions: Dr. Steve Horvath at EARD 2023Exercise Lowers SASP Levels In Seniors | Lifespan News ExtraBuilding the physical Infrastructure of Decentralized Science: Harry Gandhi at EARD 2023A Better Senescence Biomarker | Lifespan News ExtraHealthspan vs. Lifespan - Are We Asking the Wrong Question? | Longevity Biomarker Summit Panel
Lifespan Research Institute |

NOVOS AMA with CEO Chris Mirabile - EARD 2022

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER